Glial injury in neurotoxicity after pediatric CD19‐directed chimeric antigen receptor T cell therapyJuliane Gust, Rebecca Gardner, Roxana Hicks et al.|Annals of Neurology|2019Cited by 191
STRIvE-02 Arm C: Phase 1 study of concurrent PD-1 inhibition with B7-H3 CAR T cell immunotherapy for recurrent/refractory pediatric solid tumors.Michelle Choe, Navin Pinto, Mallory Taylor et al.|Journal of Clinical Oncology|2024Cited by 1